Cargando…

New acute treatments for headache

Although we have several acute care medications for the treatment of migraine, we are always looking for new medications to treat our patients. Patients often say that their headaches are not under optimal control and would be happy to try another medication. Patients look for faster onset of relief...

Descripción completa

Detalles Bibliográficos
Autor principal: Rapoport, Alan M.
Formato: Texto
Lenguaje:English
Publicado: Springer Milan 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869016/
https://www.ncbi.nlm.nih.gov/pubmed/20464603
http://dx.doi.org/10.1007/s10072-010-0304-7
_version_ 1782181094434537472
author Rapoport, Alan M.
author_facet Rapoport, Alan M.
author_sort Rapoport, Alan M.
collection PubMed
description Although we have several acute care medications for the treatment of migraine, we are always looking for new medications to treat our patients. Patients often say that their headaches are not under optimal control and would be happy to try another medication. Patients look for faster onset of relief, more complete relief, no recurrent headache and no adverse events. This article will cover some new and some anticipated acute care products, CGRP antagonists, sumatriptan by iontophoretic patch, sumatriptan by needle-free injections, DHE by oral inhalation and diclofenac potassium in a sachet. Botulinum toxin therapy, although a preventive measure, will be mentioned at the end.
format Text
id pubmed-2869016
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-28690162010-05-24 New acute treatments for headache Rapoport, Alan M. Neurol Sci Key Note Lecture Although we have several acute care medications for the treatment of migraine, we are always looking for new medications to treat our patients. Patients often say that their headaches are not under optimal control and would be happy to try another medication. Patients look for faster onset of relief, more complete relief, no recurrent headache and no adverse events. This article will cover some new and some anticipated acute care products, CGRP antagonists, sumatriptan by iontophoretic patch, sumatriptan by needle-free injections, DHE by oral inhalation and diclofenac potassium in a sachet. Botulinum toxin therapy, although a preventive measure, will be mentioned at the end. Springer Milan 2010-05-13 2010 /pmc/articles/PMC2869016/ /pubmed/20464603 http://dx.doi.org/10.1007/s10072-010-0304-7 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Key Note Lecture
Rapoport, Alan M.
New acute treatments for headache
title New acute treatments for headache
title_full New acute treatments for headache
title_fullStr New acute treatments for headache
title_full_unstemmed New acute treatments for headache
title_short New acute treatments for headache
title_sort new acute treatments for headache
topic Key Note Lecture
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869016/
https://www.ncbi.nlm.nih.gov/pubmed/20464603
http://dx.doi.org/10.1007/s10072-010-0304-7
work_keys_str_mv AT rapoportalanm newacutetreatmentsforheadache